Dare Bioscience Inc [NASDAQ: DARE] surged by $0.57 during the normal trading session on Monday and reaching a high of $9.19 during the day while it closed the day at $3.09.
Dare Bioscience Inc stock has also gained 28.75% of its value over the past 7 days. However, DARE stock has inclined by 6.92% in the 3 months of the year. Over the past six months meanwhile, it has lost -4.92% and lost -6.93% year-on date.
The market cap for DARE stock reached $27.35 million, with 8.85 million shares outstanding and 8.71 million shares in the current float. Compared to the average trading volume of 160.70K shares, DARE reached a trading volume of 71110186 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Dare Bioscience Inc [DARE]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DARE shares is $13.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DARE stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
DARE stock trade performance evaluation
Dare Bioscience Inc [DARE] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 28.75. With this latest performance, DARE shares dropped by -4.92% in over the last four-week period, additionally sinking by -4.92% over the last 6 months – not to mention a drop of -0.96% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DARE stock in for the last two-week period is set at 66.25, with the RSI for the last a single of trading hit 0.89, and the three-weeks RSI is set at 0.46 for Dare Bioscience Inc [DARE]. The present Moving Average for the last 50 days of trading for this stock 2.83, while it was recorded at 2.57 for the last single week of trading, and 3.14 for the last 200 days.
Dare Bioscience Inc [DARE]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Dare Bioscience Inc [DARE] shares currently have an operating margin of -1229.30% and a Gross Margin at 97.56%. Dare Bioscience Inc’s Net Margin is presently recorded at -191.61%.
Return on Equity for this stock declined to -16.72%, with Return on Assets sitting at -16.72%.
Dare Bioscience Inc [DARE]: Institutional Ownership
There are presently around $9.40%, or 9.55% of DARE stock, in the hands of institutional investors. The top three institutional holders of DARE stocks are: VANGUARD GROUP INC with ownership of 3.36 million shares, which is approximately 3.3271%. GEODE CAPITAL MANAGEMENT, LLC, holding 1.01 million shares of the stock with an approximate value of $$0.37 million in DARE stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$0.31 million in DARE stock with ownership which is approximately 0.9151%.
